The goal of Allrock Bio's analysis is already validated by the FDA-approved medicines for the eyes. The Biotech startup extends that science to the lungs with a drug candidate with a Sanofi license who presents the potential for a first-in-class strategy to cardiopulmonary and fibrotic ailments. Allrock is now not a stealth and divulges its technique along with $ 50 […]